Serogroup and Clonal Characterization of Czech Invasive Neisseria meningitidis Strains Isolated from 1971 to 2015
Language English Country United States Media electronic-ecollection
Document type Journal Article
Grant support
Wellcome Trust - United Kingdom
PubMed
27936105
PubMed Central
PMC5147975
DOI
10.1371/journal.pone.0167762
PII: PONE-D-16-37251
Knihovny.cz E-resources
- MeSH
- Incidence MeSH
- Humans MeSH
- Meningococcal Infections diagnosis epidemiology microbiology MeSH
- Multilocus Sequence Typing MeSH
- Neisseria meningitidis genetics isolation & purification MeSH
- Serogroup MeSH
- Bacterial Typing Techniques MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic epidemiology MeSH
BACKGROUND: This study presents antigenic and genetic characteristics of Neisseria meningitidis strains recovered from invasive meningococcal disease (IMD) in the Czech Republic in 1971-2015. MATERIAL AND METHODS: A total of 1970 isolates from IMD, referred to the National Reference Laboratory for Meningococcal Infections in 1971-2015, were studied. All isolates were identified and characterized by conventional biochemical and serological tests. Most isolates (82.5%) were characterized by multilocus sequence typing method. RESULTS: In the study period 1971-2015, the leading serogroup was B (52.4%), most often assigned to clonal complexes cc32, cc41/44, cc18, and cc269. A significant percentage of strains were of serogroup C (41.4%), with high clonal homogeneity due to hyperinvasive complex cc11, which played an important role in IMD in the Czech Republic in the mid-1990s. Serogroup Y isolates, mostly assigned to cc23, and isolates of clonally homogeneous serogroup W have also been recovered more often over the last years. CONCLUSION: The incidence of IMD and distribution of serogroups and clonal complexes of N. meningitidis in the Czech Republic varied over time, as can be seen from the long-term monitoring, including molecular surveillance data. Data from the conventional and molecular IMD surveillance are helpful in refining the antimeningococcal vaccination strategy in the Czech Republic.
See more in PubMed
Vogel U, Frosch M (1999) Mechanisms of neisserial serum resistance. Mol Microbiol 32: 1133–1139. PubMed
Pollard AJ (2004) Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 23: S274–279. PubMed
Caugant DA, Kristiansen PA, Wang X, Mayer LW, Taha MK, Ouédraogo R, et al. (2012) Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One 7: e46019 10.1371/journal.pone.0046019 PubMed DOI PMC
Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, et al. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30 Suppl 2: B26–36. PubMed
Harrison LH, Trotter CL, Ramsay ME (2009) Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2: B51–63. PubMed
Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, et al. (2012) Invasive meningococcal capsular group Y disease, England and Wales, 2007–2009. Emerg Infect Dis 18: 63–70. 10.3201/eid1801.110901 PubMed DOI PMC
Toros B, Thulin Hedberg S, Jacobsson S, Fredlund H, Olcen P, Mölling P. (2014) Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012. Euro Surveill 19. PubMed
Ladhani SN, Beebeejaun K, Lucidarme J, Campbell H, Gray S, Kaczmarski E, et al. (2015) Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales. Clin Infect Dis 60: 578–585. 10.1093/cid/ciu881 PubMed DOI
http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32012D0506&qid=1428573336660&from=EN#page=21. Accessed 6 September 2016
Surveillance of invasive meningococcal disease, Act No. 258/2000, Reg. MoH No. 473/2008, Annex 6
Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140–3145. PubMed PMC
http://pubmlst.org/neisseria/. Accessed 6 September 2016
http://emgm.eu/emert. Accessed 6 September 2016
https://tessy.ecdc.europa.eu/TessyWeb. Accessed 6 September 2016
Vackova Z, Lzicarova D, Stock NK, Kozakova J (2015) [Real-time PCR detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae DNA in clinical specimens]. Epidemiol Mikrobiol Imunol 64: 222–230. PubMed
Maiden MC (2006) Multilocus sequence typing of bacteria. Annu Rev Microbiol 60: 561–588. 10.1146/annurev.micro.59.030804.121325 PubMed DOI
Caugant DA (2008) Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect Genet Evol 8: 558–565. 10.1016/j.meegid.2008.04.002 PubMed DOI
Vogel U, Claus H (2003) Molecular epidemiology of Neisseria meningitidis. Front Biosci 8: e14–22. PubMed
Watkins ER, Maiden MC (2012) Persistence of hyperinvasive meningococcal strain types during global spread as recorded in the PubMLST database. PLoS One 7: e45349 10.1371/journal.pone.0045349 PubMed DOI PMC
Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, Musilek M, et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 42: 5146–5153. 10.1128/JCM.42.11.5146-5153.2004 PubMed DOI PMC
Jandova Z, Musilek M, Vackova Z, Kozakova J, Krizova P (2015) [Clonal analysis of the meningococcal populations from invasive disease and healthy carriers isolated in the Czech Republic in 1971–2014 (May)]. Epidemiol Mikrobiol Imunol 64: 147–152. PubMed
Brehony C, Jolley KA, Maiden MC (2007) Multilocus sequence typing for global surveillance of meningococcal disease. FEMS Microbiol Rev 31: 15–26. 10.1111/j.1574-6976.2006.00056.x PubMed DOI
Skoczynska A, Wasko I, Kuch A, Kadlubowski M, Golebiewska A, Foryś M, et al. (2013) A decade of invasive meningococcal disease surveillance in Poland. PLoS One 8: e71943 10.1371/journal.pone.0071943 PubMed DOI PMC
Ladhani SN, Flood JS, Ramsay ME, Campbell H, Gray SJ, Kaczmarski EB, et al. (2012) Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine 30: 3710–3716. 10.1016/j.vaccine.2012.03.011 PubMed DOI
Kriz P, Wieffer H, Holl K, Rosenlund M, Budhia S, Vyse A. (2011) Changing epidemiology of meningococcal disease in Europe from the mid-20th to the early 21st Century. Expert Rev Vaccines 10: 1477–1486. 10.1586/erv.11.117 PubMed DOI
Racloz VN, Luiz SJ (2010) The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology. BMC Infect Dis 10: 175 10.1186/1471-2334-10-175 PubMed DOI PMC
Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, Brehony C, et al. (2007) A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 31: 27–36. 10.1111/j.1574-6976.2006.00060.x PubMed DOI
Pollard AJ, Ochnio J, Ho M, Callaghan M, Bigham M, Dobsong S. (2004) Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. Emerg Infect Dis 10: 1812–1815. 10.3201/eid1010.040335 PubMed DOI PMC
Frosch M, Maiden MCJ (2006) Handbook of meningococcal disease: infection biology, vaccination, clinical management. Weinheim: Wiley-VCH; xlvii, 544 p. p.
Toros B, Hedberg ST, Unemo M, Jacobsson S, Hill DM, Olcén P, et al. (2015) Genome-Based Characterization of Emergent Invasive Neisseria meningitidis Serogroup Y Isolates in Sweden from 1995 to 2012. J Clin Microbiol 53: 2154–2162. 10.1128/JCM.03524-14 PubMed DOI PMC
Rosenstein NE, Perkins BA, Stephens DS, Lefkowitz L, Cartter ML, Danila R, et al. (1999) The changing epidemiology of meningococcal disease in the United States, 1992–1996. J Infect Dis 180: 1894–1901. 10.1086/315158 PubMed DOI
Krauland MG, Dunning Hotopp JC, Riley DR, Daugherty SC, Marsh JW, Messonnier NE, et al. (2012) Whole genome sequencing to investigate the emergence of clonal complex 23 Neisseria meningitidis serogroup Y disease in the United States. PLoS One 7: e35699 10.1371/journal.pone.0035699 PubMed DOI PMC
Neri A, Fazio C, Carannante A, Mastrantonio P, Stefanelli P (2012) Diversity of Neisseria meningitidis invasive isolates in Italy in the period 2008–2010. J Prev Med Hyg 53: 109–112. PubMed
Teyssou R, Muros-Le Rouzic E (2007) Meningitis epidemics in Africa: a brief overview. Vaccine 25 Suppl 1: A3–7. PubMed
Kristiansen PA, Diomande F, Ba AK, Sanou I, Ouedraogo AS, Ouédraogo R, et al. (2013) Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 56: 354–363. 10.1093/cid/cis892 PubMed DOI
Nicolas P, Decousset L, Riglet V, Castelli P, Stor R, Blanchet G. (2001) Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa. Emerg Infect Dis 7: 849–854. 10.3201/eid0705.010513 PubMed DOI PMC
Ibarz-Pavon AB, Maclennan J, Andrews NJ, Gray SJ, Urwin R, Clarke SC, et al. (2011) Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis 204: 1046–1053. 10.1093/infdis/jir466 PubMed DOI PMC
Campbell H, Saliba V, Borrow R, Ramsay M, Ladhani SN (2015) Targeted vaccination of teenagers following continued rapid endemic expansion of a single meningococcal group W clone (sequence type 11 clonal complex), United Kingdom 2015. Euro Surveill 20. PubMed
Wilder-Smith A, Goh KT, Barkham T, Paton NI (2003) Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers. Clin Infect Dis 36: 679–683. 10.1086/367858 PubMed DOI
Mustapha MM, Marsh JW, Harrison LH (2016) Global epidemiology of capsular group W meningococcal disease (1970–2015): Multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine 34: 1515–1523. 10.1016/j.vaccine.2016.02.014 PubMed DOI
Krizova P, Musilek M, Vackova Z, Becvarova Z, Kozakova J (2014) [Sequencing analysis of the antigens included in the four-component vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from 2007–2013]. Epidemiol Mikrobiol Imunol 63: 61–68. PubMed
NIPH website. http://www.szu.cz/uploads/IMO/Recommendation_for_vaccination_IMD.pdf. Accessed 6 September 2016